AI in IVF Treatment: How Artificial Intelligence Is Changing Fertility Care

Artificial intelligence (AI) is transforming many areas of healthcare, including fertility treatment. In in vitro fertilisation (IVF), AI-powered tools are being developed to analyse embryo images, assess sperm movement, support fertility monitoring and help doctors make more informed treatment decisions.

But what does AI in IVF actually mean for couples trying to conceive? Can artificial intelligence improve embryo selection or increase IVF success rates? And will AI replace fertility specialists and embryologists?

The answer is more nuanced than the headlines suggest. AI can help analyse complex medical images and data, but its usefulness depends on the technology, the quality of the evidence, and how the clinical team uses it.

In this guide, we explain how AI in IVF treatment works, its potential benefits and limitations, and what patients should know when exploring fertility care in India.

What Is AI in IVF Treatment?

AI in IVF refers to using artificial intelligence and machine-learning systems to analyse information collected during fertility treatment. These systems may assess embryo images, sperm characteristics, ultrasound scans and other clinical data to identify patterns that could support medical decisions.

For example, an AI-assisted embryo assessment system may analyse images of developing embryos and generate a score to help embryologists compare them. Another tool may help measure ovarian follicles during IVF stimulation monitoring.

AI does not independently understand every aspect of a patient’s fertility. Instead, it processes specific types of data according to how the system was developed and validated.

The key point: AI is a decision-support technology. Fertility specialists and embryologists remain responsible for interpreting results and making treatment decisions with patients.

How Is Artificial Intelligence Used in IVF?

AI applications in fertility care are developing rapidly. Some are in clinical settings, while others are still under evaluation.

1. AI-Powered Embryo Selection

Embryo assessment is one of the most widely discussed AI applications in IVF.

During an IVF cycle, embryologists examine developing embryos to assess their appearance and development. Depending on the laboratory, they may also use time-lapse imaging, which captures images of embryos at regular intervals while they remain in a controlled incubator environment.

AI systems can analyse these images to identify developmental patterns and generate scores that may help prioritise embryos for further consideration.

Potential benefits include:

• Supporting more consistent embryo assessment.
• Analysing developmental patterns that may be difficult to evaluate manually.
• Helping embryologists compare embryos using a structured scoring system.
• Providing additional information during embryo-transfer planning.

However, an AI-generated score does not guarantee implantation, pregnancy, or live birth. The clinical value of embryo-ranking tools varies, and the results must be interpreted alongside established embryology assessments and the patient’s circumstances.

2. Time-Lapse Embryo Imaging and AI

Time-lapse embryo imaging allows embryologists to observe embryo development over time without repeatedly removing embryos from the incubator for routine visual checks.

When combined with AI, this technology can analyse developmental timing and other visible characteristics. These patterns are sometimes described as morphokinetics.

AI may use these observations to help identify differences in embryo development. Nevertheless, time-lapse imaging and AI scoring are not the same thing, and using either technology does not automatically improve IVF outcomes.

Patients can ask their fertility specialist whether time-lapse imaging or AI-assisted assessment is available and appropriate for their treatment.

3. AI in Sperm Analysis and Male Infertility

Male-factor infertility can involve low sperm count, reduced motility, abnormal morphology or other sperm-related problems.

Computer-assisted sperm analysis uses imaging and software to measure characteristics such as sperm concentration and movement. Researchers are also developing AI-based methods to support more detailed sperm assessment.

Potential applications include:

• Analysing sperm movement patterns.
• Supporting objective measurement of sperm characteristics.
• Helping researchers investigate sperm selection methods.
• Exploring new approaches for certain cases of male-factor infertility.

Some AI-based sperm-selection methods remain experimental or have limited clinical evidence. AI analysis should not be confused with a definitive test of sperm DNA integrity or a guarantee that a selected sperm will produce a healthy pregnancy.

For couples considering IVF or intracytoplasmic sperm injection (ICSI), the appropriate approach depends on the male partner’s assessment and the fertility specialist’s recommendations.

4. AI-Assisted Follicle Monitoring During IVF

During ovarian stimulation, patients generally undergo ultrasound scans and, when appropriate, blood tests to monitor their response to fertility medication.

AI-assisted ultrasound analysis is being developed to help identify, count and measure ovarian follicles. These measurements may help the clinical team review follicular growth throughout treatment.

Possible benefits include:

• More efficient analysis of ultrasound images.
• Consistent follicle measurement.
• Support for tracking changes across multiple scans.
• Additional information for treatment monitoring.

However, decisions about medication doses and the timing of the final maturation trigger must consider the complete clinical picture. AI should not make these decisions independently.

5. Personalised IVF Treatment and Outcome Prediction

Every patient has a different fertility history. Age, ovarian reserve, previous treatment response, sperm factors and other medical considerations can influence IVF planning.

Machine-learning models can analyse clinical datasets to explore patterns associated with ovarian stimulation response or treatment outcomes. In selected settings, these tools may support clinical decision-making.

Potential applications include:

• Estimating the likely response to ovarian stimulation.
• Supporting discussions about treatment options.
• Analysing patterns across previous IVF cycles.
• Helping clinicians communicate uncertainty around treatment outcomes.

These predictions have important limitations. A model’s accuracy depends on the data used to develop and validate it, and a prediction generated for one patient group may not perform equally well in another.

An estimated probability does not guarantee an individual outcome. Patients should discuss how any prediction was generated and what it means for their particular treatment.

6. Electronic Witnessing and IVF Laboratory Safety

Not all important fertility technologies use artificial intelligence.

Electronic witnessing systems use identification and tracking processes to help verify that eggs, sperm and embryos are correctly associated with the relevant patient during laboratory procedures. They aim to reduce the risk of identification errors.

These systems should be distinguished from AI-powered embryo selection. Both may form part of a modern IVF laboratory’s technology infrastructure, but they serve different purposes.

Laboratory automation and digital tracking can support workflow consistency, while trained professionals and established quality-control procedures remain essential.

AI in IVF: Technology and Its Potential Role

The availability of these technologies varies between fertility centres. Not every clinic offers every application, and not every tool has the same level of clinical evidence.

Does AI Improve IVF Success Rates?

This is one of the most important questions for patients considering AI-assisted fertility treatment.

The honest answer is that AI shows promise, but we have not established that every AI-based IVF tool improves clinical pregnancy or live-birth rates compared with standard care.

A multicentre randomised trial published in Nature Medicine in 2024 evaluated deep-learning-based embryo selection using iDAScore. The clinical pregnancy rate was 46.5% in the AI-assisted group and 48.2% in the group using standard embryo morphology assessment and a predefined prioritisation approach. The trial did not establish noninferiority of the AI method to the standard approach for its primary outcome.

This finding highlights an important distinction: an AI system may analyse images well without improving the outcomes that matter most to patients.

The American Society for Reproductive Medicine’s 2026 committee opinion on AI in the IVF laboratory also recommends caution when interpreting the evidence, particularly findings based on retrospective data.

For patients, the practical takeaways are:

• AI-assisted embryo assessment does not guarantee pregnancy.
• Results from one AI system cannot automatically be applied to another.
• Laboratory performance and patient outcomes are different measures.
• A clinic’s overall clinical care and laboratory quality remain important.

For further reading, see the randomised trial published in Nature Medicine and the American Society for Reproductive Medicine’s guidance on AI in the IVF laboratory.

What Are the Limitations of AI in Fertility Treatment?

Although AI can support fertility care, several limitations deserve attention.

1. AI depends on the quality of its training data

An AI system learns patterns from the data used to develop it. If that data does not adequately represent the patients and clinical settings where the system will be used, its performance may be less reliable.

2. Some AI decisions are difficult to explain

Certain models produce scores or rankings without providing a straightforward explanation for each result. This can make independent interpretation challenging.

3. AI does not replace clinical expertise

Fertility treatment involves medical history, diagnostic findings, patient preferences and clinical judgement. An algorithm cannot independently account for every factor relevant to a patient’s care.

4. Regulatory status and validation differ

Different AI tools have different intended uses and levels of testing. Patients should not assume that every product marketed as AI-powered has equivalent evidence, regulatory clearance or clinical value.

5. Better predictions do not necessarily mean better outcomes

An algorithm may classify embryos or estimate probabilities accurately under certain conditions, but that does not prove it increases the chance of a live birth. Clinical studies are needed to establish meaningful benefits.

The most responsible approach is to use validated technologies where appropriate, monitor their performance and maintain qualified human oversight.

What Does AI in IVF Mean for Patients in India?

For patients exploring fertility treatment in India, advanced technology can help you understand a clinic’s approach. However, AI alone should not determine which fertility centre to choose.

Patients considering IVF in Srinagar, Kashmir or elsewhere in India can ask their clinic:

• Which AI-assisted technologies, if any, are used in the laboratory?
• What specific clinical task does each technology support?
• Has the technology been independently validated for that intended use?
• How do embryologists interpret AI-generated scores?
• What evidence is available for clinical pregnancy and live-birth outcomes?
• How are patient information, images and laboratory data protected?

These questions help patients distinguish between a genuinely useful clinical tool and a technology claim that may be primarily promotional.

For more information about fertility care in the region, visit Imprimis IVF

The Future of Artificial Intelligence in IVF

Research into AI-assisted fertility treatment continues to expand. Areas of investigation include embryo assessment, sperm analysis, ultrasound interpretation, clinical outcome prediction, and integrating different types of patient data.

Future systems may help clinicians interpret complex information more efficiently. However, their value will depend on prospective clinical studies, independent validation, appropriate regulation and evidence that they improve patient care.

In India, wider adoption will also depend on cost, accessibility, infrastructure, training and the ability to maintain consistent laboratory standards.

The future of IVF is unlikely to depend on AI alone. Instead, it will involve a combination of medical expertise, embryology, laboratory quality, carefully evaluated technology and individualised patient care.

The Imprimis IVF Approach to Technology and Fertility Care

At Imprimis IVF & Fertility Centre, patients should receive clear information about their treatment options, the role of laboratory technology, and the evidence supporting any recommended technology.

When discussing IVF, it is important to understand what a particular tool can and cannot do, and how the clinical team uses its findings.

When available and appropriate, AI-assisted assessment should support qualified professionals rather than replace their judgement. Fertility care aims not simply to adopt new technology, but to make informed decisions that reflect each patient’s clinical needs.

If you are exploring IVF treatment in Srinagar, speak with a fertility specialist about your diagnosis, available treatment options, laboratory procedures and realistic expectations.

Looking for guidance about IVF treatment in Srinagar? Visit Imprimis IVF & Fertility Centre to learn more about fertility treatment and discuss your individual needs with the clinical team.

Frequently Asked Questions About AI in IVF

1. What is AI in IVF treatment?

AI in IVF refers to computer systems that analyse specific medical images and clinical data to support tasks such as embryo assessment, sperm analysis, and fertility monitoring. Its role depends on the particular technology being used.

2. Can AI embryo selection increase IVF success rates?

AI may help assess and prioritise embryos, but it has not consistently been shown that AI-assisted selection improves live-birth rates compared with standard methods. Results vary by technology, and further clinical evidence is needed.

3. Does AI select the embryo instead of an embryologist?

No. AI can generate scores or rankings to support embryo assessment. Qualified embryologists and fertility specialists interpret those results alongside other relevant information and make clinical decisions.

4. Is AI-powered IVF available in India?

The availability of AI-assisted fertility technologies varies by clinic and application. Patients should ask which specific tools are used, what evidence supports them and whether they are appropriate for their treatment.

5. Is AI in IVF safe and reliable?

Reliability depends on the system’s intended use, validation, data quality and clinical oversight. Evaluate AI tools individually, and do not treat their outputs as definitive medical conclusions.

6. What is the difference between AI embryo selection and time-lapse imaging?

Time-lapse imaging records embryo development over time. AI embryo selection uses software to analyse images or developmental data and may generate scores to support embryo prioritisation. The two technologies can be used together, but they are not interchangeable.

7. Can AI predict whether IVF will succeed?

Some models estimate selected treatment outcomes using clinical data. These estimates involve uncertainty and cannot guarantee pregnancy or live birth. A fertility specialist can explain how to interpret relevant predictions.

8. Should I choose a fertility clinic because it uses AI?

Not on that basis alone. Consider the fertility team’s qualifications, laboratory standards, transparency, appropriate treatment planning, and the quality of clinical evidence. Ask whether a particular technology offers a meaningful benefit for your circumstances.

Medical information notice: This article is for educational purposes only and is not a substitute for personalised medical advice. IVF treatment decisions should be made with a qualified fertility specialist.